南臺灣醫學雜誌 (Record no. 7396)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 00923cas a2200241 i 4500 |
| 001 - CONTROL NUMBER | |
| control field | .b47689109 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | YEEZEN |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20230208135905.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 130904c20069999ch fr p r 0 0e0chi d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1991-4784 (平裝) |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NTU |
| Language of cataloging | chi |
| Transcribing agency | NTU |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | nbic |
| 066 ## - CHARACTER SETS PRESENT | |
| Primary G0 character set | $1 |
| 245 00 - TITLE STATEMENT | |
| Title | 南臺灣醫學雜誌 |
| Remainder of title | Medical journal of south Taiwan. |
| 246 11 - VARYING FORM OF TITLE | |
| Title proper/short title | Medical journal of south Taiwan. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | 高雄市 : |
| Name of publisher, distributor, etc. | 聯合出版醫院, |
| Date of publication, distribution, etc. | 2006- |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 冊 : |
| Other physical details | 圖 ; |
| Dimensions | 30公分 |
| 310 ## - CURRENT PUBLICATION FREQUENCY | |
| Current publication frequency | 半年刊 |
| 362 0# - DATES OF PUBLICATION AND/OR SEQUENTIAL DESIGNATION | |
| Dates of publication and/or sequential designation | 第1卷第1期(2006年6月)- |
| 500 ## - GENERAL NOTE | |
| General note | 題名取自封面 |
| 500 ## - GENERAL NOTE | |
| General note | 本刊由高雄市國軍高雄總醫院, 高雄市立民生醫院, 臺南市郭綜合醫院, 屏東市寶建醫院, 屏東市行政院衛生署屏東醫院, 屏東縣東港安泰醫院, 高雄市阮綜合醫院, 高雄市國軍左營總醫院聯合出版 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | 醫學. |
| Source of heading or term | lcstt. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | 期刊. |
| Source of heading or term | lcstt. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | 聯合出版醫院 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Koha item type | 期刊 |
| 撤銷狀態 | 遺失狀態 | 分類號來源 | 損壞狀態 | 不外借 | 永久館藏地 | 現在館藏地 | 書架位置 | 採購日期 | 全部借出 | 完整索書號 | 條碼號 | 最後一次日期記錄 | 複本號 | 一般價格有效日期 | Koha館藏類型 | 公開資訊 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 未註銷館藏 | 未遺失 | 未損毀 | 可外借 | 怡仁綜合醫院圖書館 | 怡仁綜合醫院圖書館 | 2023-02-08 | Vol.16 N.1 | F00047 | 2023-02-08 | Vol.16 N.1 | 2023-02-08 | 期刊 | Objective: This study investigated depression, self-care and quality of life in women with gynecological cancer in southern Taiwan. Methods: A cross-sectional design investigation method was adopted to facilitate the sampling of 350 gynecological cancer women were recruited through convenience sampling, at a teaching district hospital in southern Taiwan. Data were collected by delivering an interview survey of structured questionnaires. Outcome measurements included basic data, self-care scales, depression scales, and quality of life scales. Data were analyzed using SPSS 21.0 statistical software. Results: The results revealed a statistically significant negative correlation between self-care and occupation as well as between age and family type. Depression in women with cancer was negatively correlated with quality of life and positively correlated with self-care. These four factors accounted for 27.1% of the total variance in self-care; support from friends and poor sleep quality were two predictors of quality of life, accounting for 53.1% of the total variance. Conclusion: The results provide a reference for Clinical practice, administrative, and medical education can improve to the quality of life of women with gynecological cancer. | |||
| 未註銷館藏 | 未遺失 | 未損毀 | 可外借 | 怡仁綜合醫院圖書館 | 怡仁綜合醫院圖書館 | 2023-02-08 | Vol.16 N.2 | F00048 | 2023-02-08 | Vol.16 N.2 | 2023-02-08 | 期刊 | Objective: Hepatocarcinogenesis is a complex process and hard to understand. By an ideal mathematical calculation in 2009, I found the hepatocarcinogenesis might be constituted by 6 molecular pathway permutations. By understanding the progress of hepatocellular carcinoma drugs in the past 10 years, I will verify its correctness and will explain the current status of hepatocellular carcinoma drug treatment. Methods: Review associated 2010-2020 Pub-med articles about advanced hepatocellular carcinoma drugs treatment and the IMbrave 150 study. Results: The IMbrave 150 study confirms my previous theoretical prediction ＂if we use 1 or 2 key molecular targeted therapies, the disease control rate will be 41-51% and 59-76% respectively.＂ Both anti-PD1/PDL1 and anti-VEGF can treat 2 targeted pathways of the 6 molecular pathways of hepatocarcinogenesis. Conclusion: The ideal mathematical calculation/model in 2009 by Dr. Huang et al. could explain the progress of medical treatment of hepatocellular carcinoma in the past ten years and it could predict future combinations of therapeutic development and direction. |